title: Timing of allogeneic BMT for CML patients in India: does it affect response?
authors.forename: Sudha
authors.initials: S
authors.lastname: Sazawal
authors.forename: Syed Khizer
authors.initials: SK
authors.lastname: Hasan
authors.forename: Bijender
authors.initials: B
authors.lastname: Kumar
authors.forename: Rajat
authors.initials: R
authors.lastname: Kumar
authors.forename: Lalit
authors.initials: L
authors.lastname: Kumar
authors.forename: Renu
authors.initials: R
authors.lastname: Saxena
mesh_terms: D000328:Adult; D016026:Bone Marrow Transplantation / Q000379:methods*; D005260:Female; D016313:Genes, abl / Q000235:genetics; D006801:Humans; D007194:India; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000628:therapy*; D008297:Male; D010865:Pilot Projects; D013997:Time Factors; D014184:Transplantation, Homologous / Q000379:methods; D016896:Treatment Outcome